Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

NCT01099540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Samsung Cancer Center Seoul, South Korea

View Trial Details

Completed

Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)

NCT00610129

Conditions: Metastatic Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States

View Trial Details

Completed

B-Receptor Signaling in Cardiomyopathy

NCT01135849

Conditions: Adenocarcinoma, Adenoma, Amyloidosis, +140 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)

NCT02539433

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: North Shore University Hospital Manhasset, New York, United States

View Trial Details

Completed

DOTA-TOC in Metastasized Neuroendocrine Tumors

NCT00978211

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University Hospital Basel, Canton of Basel-City, Switzerland

View Trial Details

Completed

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

NCT00753415

Conditions: Adenocarcinoma, Bladder Carcinoma, Breast Cancer, +56 more
Locations: Not specified

View Trial Details

Completed

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

NCT00131911

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +28 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

NCT01121562

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Aichi Cancer Center Central Hospital Nagoya, Aichi-ken, Japan

Kyushu University Hospital Fukuoka, Japan

Osaka Police Hospital Osaka, Japan

National Cancer Center Hospital Chuo-ku, Tokyo, Japan

View Trial Details

Completed

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

NCT00942682

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +18 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

NCT00363051

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +18 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

USC Medical Center Los Angeles, California, United States

Cedars-Sinai Outpatient Cancer Center/Samuel Oschin Comprehensive Cancer Inst. Los Angeles, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 54 locations

View Trial Details